8/16/2011

Beginning today, pharmaceutical firms must allow user comments on most of their Facebook pages to "encourage an authentic dialogue" on the social network. Drugmakers are worried that users will post inappropriate statements, which could prompt regulatory concerns. AstraZeneca deleted a page devoted to depression last week, while Johnson & Johnson intends to remove four pages this week.

Related Summaries